All filters
Abstracts
Prevalence and the impact of low-level viremia among people living with HIV taking protease inhibitors or dolutegravir-based antiretroviral therapy
G. Chen
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
High retention but low virological suppression rates among HIV-infected infants with early antiretroviral treatment in the Thai national program
T. Puthanakit
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Comparison of digital and facility-based HIV/Syphilis self-testing secondary distribution modes among men who have sex with men in China
Y. Sha
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Modified self-obtained pooled sampling to screen for Chlamydia trachomatis and Neisseria gonorrhoeae infection in men who have sex with men
N. Ando
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
HCV surges among Thai MSM with HIV, fueled by crystal methamphetamine and group sex
A. Varma
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Associated factors with sexually transmitted hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan
Y. Chen
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Cost-Saving of Pooled HCV RNA Testing to Diagnose Acute HCV Infection in High-Risk Populations
H. Sun
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Drug resistance to novel non-nucleoside reverse transcriptase inhibitor Elsulfavirine among treatment-naïve, HIV-infected Caucasian and Asian patients
A. Kirichenko
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Durable efficacy of dolutegravir (DTG) plus lamivudine (3TC) in antiretroviral treatment–naive adults with HIV-1 infection: 96-week results from the GEMINI studies in participants from Asian centres
C. Yang
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Efficacy and Safety of Switching to B/F/TAF in Virologically Suppressed Asian Adults Living with HIV
A. Avihingsanon
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Pooled Analysis of the Efficacy, Safety, and Health Outcomes Following 48 Weeks of Long-acting Cabotegravir and Rilpivirine Maintenance Therapy for HIV-1 Infection in Phase 3 ATLAS and FLAIR Studies: Sub-Analysis in Asian Populations
J. Choi
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Efficacy and Safety of Switching to B/F/TAF in Virologically Suppressed Asian Women living with HIV
H. Wang
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Assessment of the safety of dolutegravir in HIV-infected patients from China: A real-world, open-label, multicenter, post-marketing surveillance study
F. Zhang
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Treatment Persistence among HIV-1 Patients Initiating Antiretroviral Therapy in Japan
T. Naito
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Safety and Efficacy of Genvoya® (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide, EVG/C/F/TAF) from the 3rd year Post Market Surveillance (PMS) Data in Korea
Y. Kim
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
The impact of gender on the clinical course of HIV infection in Yangon, Myanmar
P. Nyein
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Anti-Müllerian hormone levels and related factors of 715 HIV-infected women in childbearing age
D. Gong
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Analysis of total HIV-1DNA in peripheral blood after HAART in HIV-1/ HCV co-infected patients
C. Wen
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Switch-rate and switch-pattern of patients on 2-drug antiretroviral treatment – comparison to 3-drug regimen in a Japanese hospital claim database
D. Ruzicka
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
The Changes of Health-Related Quality-of-Life and Sleep Quality Following the Switch of Anti- Retroviral Treatment in Patients with Well-Controlled HIV Infection.
Y. Yoshino
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Factors associated with high alanine aminotransferase (ALT) and cirrhosis in people living with HIV on combination antiretroviral treatment (cART) in the Asia-Pacific
D. Rupasinghe
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Association of body mass index with immune recovery, virologic failure and cardiovascular disease risks among people living with HIV
W. Han
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Patient-Reported Outcomes and Body Weight Change among Patients Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide
L. Chen
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Effects of Syphilis Infection among HIV-1-Positive Individuals on Suppressive ART
P. Chan
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020